These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8103222)

  • 1. Residual and negative symptoms in treatment with neuroleptics.
    Kane JM
    Psychopharmacol Ser; 1993; 10():131-7. PubMed ID: 8103222
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.
    Prosser ES; Csernansky JG; Kaplan J; Thiemann S; Becker TJ; Hollister LE
    J Nerv Ment Dis; 1987 Feb; 175(2):100-5. PubMed ID: 2879880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 7. Negative priming (cognitive inhibition) in psychiatric patients: effect of neuroleptics.
    David AS
    J Nerv Ment Dis; 1995 May; 183(5):337-9. PubMed ID: 7745390
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology and treatment of negative symptoms.
    Villeneuve A
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia.
    Jhamnani K; Shivakumar V; Kalmady S; Rao NP; Venkatasubramanian G
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E06-7. PubMed ID: 23487204
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T; Brown KW; Woods JP
    Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant usage in schizophrenia.
    Plasky P
    Schizophr Bull; 1991; 17(4):649-57. PubMed ID: 1687176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine.
    Bodkin JA; Cohen BM; Salomon MS; Cannon SE; Zornberg GL; Cole JO
    J Nerv Ment Dis; 1996 May; 184(5):295-301. PubMed ID: 8627275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia.
    Wyatt RJ
    Schizophr Res; 1991 Oct; 5(3):201-2. PubMed ID: 1684719
    [No Abstract]   [Full Text] [Related]  

  • 14. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Revealed" Depression and drug treatment for schizophrenia.
    Knights A; Hirsch SR
    Arch Gen Psychiatry; 1981 Jul; 38(7):806-11. PubMed ID: 6113822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract]   [Full Text] [Related]  

  • 19. Subjective response to neuroleptics and the quality of life: implications for treatment outcome.
    Awad AG; Hogan TP
    Acta Psychiatr Scand Suppl; 1994; 380():27-32. PubMed ID: 7914044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Postpsychotic depression" and residual schizophrenia in a mental health hospital.
    Mauri MC; Laini V; Barone R; Clemente A; Volonteri LS; Cerveri G; Steinhilber C; Fornier M
    Encephale; 2000; 26(6):21-6. PubMed ID: 11217534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.